FAS-AS1 up-regulation | FAS-AS1 down-regulation | P value | HOTAIRM1 up-regulation | HOTAIRM1 Down-regulation | P value | NEAT1 up-regulation | NEAT1 down-regulation | P value | PVT1 up-regulation | PVT1 down-regulation | P value | THRIL up-regulation | THRIL down-regulation | P value | TUG1 up-regulation | TUG1 down-regulation | P value | GAS5 up-regulation | GAS5 down-regulation | P value | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | 1 | 0.48 | 0.48 | 0.723 | 0.476 | 0.723 | 0.723 | ||||||||||||||
< 60 years | 8(50%) | 8(50%) | 9 (56.3%) | 7(43.8%) | 9(56.2%) | 7(43.8) | 9(56.3%) | 7(43.8%) | 10(62.5%) | 6(37.5%) | 9(56.2%) | 7(43.8) | 7(43.8%) | 9(56.3%) | |||||||
≥60 years | 8(50%) | 8(50%) | 7(43.8%) | 9(56.3%) | 7(43.8) | 9(56.2%) | 8(50%) | 8(50%) | 8(50%) | 8(50%) | 8(50%) | 8(50%) | 8(50%) | 8(50%) | |||||||
Smoking | 1 | 1 | 1 | 1 | 0.426 | 0.272 | 0.678 | ||||||||||||||
Yes | 13(52%) | 12(48%) | 12(48%) | 13(52%) | 12(48%) | 13(52%) | 13(52%) | 12(48%) | 13(52%) | 12(48%) | 12(48%) | 13(52%) | 11(44%) | 14(56%) | |||||||
No | 3(42.9%) | 4(57.1%) | 4(57.1%) | 3(42.9%) | 4(57.1%) | 3(42.9%) | 4(57.1%) | 3(42.9%) | 5(71.4%) | 2(28.6%) | 5(71.4%) | 2(28.6%) | 4(57.1%) | 3(42.9%) | |||||||
Stage | 0.148 | 0.148 | 0.538 | 0.73 | 1 | 0.165 | 0.39 | ||||||||||||||
1 | 6(85.7%) | 1 (14.3%) | 6(85.7%) | 1 (14.3%) | 5(71.4%) | 2(28.6%) | 3(42.9%) | 4(57.1%) | 4(57.1%) | 3(42.9%) | 6(85.7%) | 1 (14.3%) | 5(71.4%) | 2(28.6%) | |||||||
2 | 4(36.4%) | 7(63.6%) | 4(36.4%) | 7(63.6%) | 5(45.5%) | 6(54.5%) | 7(63.6%) | 4(36.4%) | 6(54.5%) | 5(45.5%) | 5(45.5%) | 6(54.5%) | 4(36.4%) | 7(63.6%) | |||||||
3 | 6(42.9%) | 8(57.1%) | 6(42.9%) | 8(57.1%) | 6(42.9%) | 8(57.1%) | 7(50%) | 7(50%) | 8(57.1%) | 6(42.9%) | 6(42.9%) | 8(57.1%) | 6(42.9%) | 8(57.1%) | |||||||
Subtype | 0.476 | 1 | 1 | 0.688 | 0.53 | 0.688 | 0.305 | ||||||||||||||
Adenocarcinoma | 8(44.8%) | 10(55.6%) | 9 (50%) | 9 (50%) | 9 (50%) | 9 (50%) | 9 (50%) | 9 (50%) | 11(61.1%) | 7(38.9%) | 9 (50%) | 9 (50%) | 7(38.9%) | 11(61.1%) | |||||||
Squamous cell carcinoma | 8(57.1%) | 6 (42.9%) | 7 (50%) | 7 (50%) | 7 (50%) | 7 (50%) | 8 (57.1%) | 9 (42.9%) | 7 (50%) | 7 (50%) | 8 (57.1%) | 6 (42.9%) | 8(57.1%) | 6 (42.9%) |